Medicine,
Год журнала:
2024,
Номер
103(15), С. e37717 - e37717
Опубликована: Апрель 12, 2024
Cancer
incidence
is
increasingly
seen
in
younger
individuals.
Molecular
distinctions
between
young
and
elderly
patients
at
onset
are
understudied.
This
study
used
public
databases
to
explore
genomic,
transcriptomic,
immune-related
features
across
age
groups
cervical
cancer.
Additionally,
it
aims
create
a
prognostic
model
applicable
diverse
cohorts,
enabling
precise
patient
stratification,
personalized
therapies.
Gene
mutations,
expression
data,
clinicopathological
information
were
obtained
from
317
cancer
patients.
These
divided
into
group
an
old
based
on
the
median
of
onset.
The
characteristics
differential
gene
mutation,
expression,
immune
cells
analysis
analyzed
by
R
software.
Finally,
was
constructed
univariate
Cox,
least
absolute
shrinkage
selection
operator,
multivariate
Cox
regression
analyses
angiogenic
sets.
Its
validity
further
confirmed
using
additional
300
squamous
cell
carcinoma
endocervical
adenocarcinoma
tissues.
Cervical
exhibit
significantly
higher
frequency
NOTCH1
TP53
driver
mutations
compared
patients,
along
with
notably
tumor
mutational
burden.
However,
there
no
significant
differences
2
terms
genomic
instability
age-related
signatures.
Differential
revealed
that
upregulated
interferon-alpha
gamma
responses
exhibited
activity
multiple
metabolic
pathways.
Immune
microenvironment
indicated
enrichment
dendritic
natural
killer
group,
while
transforming
growth
factor-β
signature
enriched
indicating
degree
exclusion.
A
multigene
angiogenesis
T
sets
showed
excellent
performance
independent
clinical
factors
such
as
age.
High-risk
identified
activation
tumor-promoting
processes,
metastasis
angiogenesis.
Our
reveals
distinct
patterns
cancer-driving
mechanisms,
biological
system
status
findings
shed
light
age-specific
underlying
mechanisms
carcinogenesis.
Furthermore,
molecular
provide
valuable
references
for
stratification
development
potential
drug
targets.
Biomedicine & Pharmacotherapy,
Год журнала:
2023,
Номер
164, С. 114954 - 114954
Опубликована: Май 29, 2023
Traditionally,
vaccines
have
helped
eradication
of
several
infectious
diseases
and
also
saved
millions
lives
in
the
human
history.
Those
prophylactic
acted
through
inducing
immune
responses
against
a
live
attenuated,
killed
organism
or
antigenic
subunits
to
protect
recipient
real
infection
caused
by
pathogenic
microorganism.
Nevertheless,
development
anticancer
as
valuable
targets
health
has
faced
challenges
requires
further
optimizations.
Dendritic
cells
(DCs)
are
most
potent
antigen
presenting
(APCs)
that
play
essential
roles
tumor
immunotherapies
induction
CD8+
T
cell
immunity.
Accordingly,
various
strategies
been
tested
employ
DCs
therapeutic
for
exploiting
their
activity
cells.
Application
whole
purified/recombinant
peptides
common
approaches
pulsing
DCs,
which
then
injected
back
into
patients.
Although
some
hopeful
results
reported
number
DC
animal
clinical
trials
cancer
patients,
such
still
inefficient
require
optimization.
Failure
vaccination
is
postulated
due
immunosuppressive
microenvironment
(TME),
overexpression
checkpoint
proteins,
suboptimal
avidity
tumor-associated
(TAA)-specific
lymphocytes,
lack
appropriate
adjuvants.
In
this
review,
we
an
overview
current
experiments
evaluated
efficacy
well
focusing
on
improve
potential
including
combination
therapy
with
inhibitors
(ICIs).
Cell Communication and Signaling,
Год журнала:
2024,
Номер
22(1)
Опубликована: Фев. 10, 2024
Abstract
Cervical
cancer
(CC)
is
a
common
gynecologic
malignancy,
accounting
for
significant
proportion
of
women
death
worldwide.
Human
papillomavirus
(HPV)
infection
one
the
major
etiological
causes
leading
to
CC
onset;
however,
genetic,
and
epigenetic
factors
are
also
responsible
disease
expansion.
Circular
RNAs
(circRNAs),
which
known
as
particular
subset
non-coding
RNA
(ncRNA)
superfamily,
with
covalently
closed
loop
structures,
have
been
reported
be
involved
in
progression
diverse
diseases,
especially
neoplasms.
In
this
framework,
abnormally
expressed
circRNAs
strong
correlation
pathogenesis
through
regulating
substantial
signaling
pathways.
Also,
these
molecules
can
considered
promising
biomarkers
therapeutic
targets
diagnosis/prognosis
treatment,
respectively.
Herein,
we
first
review
key
molecular
mechanisms,
including
Wnt/β-catenin,
MAPK,
PI3K/Akt/mTOR
pathways,
well
angiogenesis
metastasis,
by
interfere
development.
Then,
diagnostic,
prognostic,
potentials
ncRNA
will
highlighted
depth.